Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The study population will include total of 200 adults (age range of 18 - 85 years) who are in the American Society of Anesthesiologists (ASA) Physical Status (PS) 1-3. Inclusion criteria are patients undergoing unilateral, primary, total hip arthroplasty.~Exclusion Criteria:~* Exclusion criteria include patient's refusal, patients with history of significant coagulopathy or on anticoagulation therapy. Female patients who are pregnant or nursing will be excluded. In addition, patients with anemia (Hb \< 8 g/dL) or who received blood transfusion within one week before surgery will be excluded. Patient receiving subcutaneous heparin on the same day prior to surgery will be also excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- tranexamic acid (Type: EXPERIMENTAL): Patients undergoing unilateral, primary, total hip arthroplasty with English as their native language
- Normal saline (Type: PLACEBO_COMPARATOR): Patients undergoing unilateral, primary, total hip arthroplasty with English as their native language

Based on this trial design, predict the completion outcome and termination type (if applicable).